Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism

Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism

Conditions: Subclinical Hypothyroidism
Interventions: Drug: Levothyroxine; Other: Placebo
Sponsors: VA Office of Research and Development; Central Arkansas Veterans Healthcare System
Completed

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 19, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments